In the E2F: ON position, G1-accelerated tumor cells exhibit a short G1 phase due to increased expression of direct and indirect mitogens (e.g., Myc and HER2) or direct E2F activators (e.g., cyclin D1 and cyclin E2) as G1 kinase complexes. This evidence concerns the gene ERBB2 and neoplasm.